Brian C. Bock

Fidelity Management & Research Co. (FMR) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1946 and is a subsidiary of FMR LLC, also known as Fidelity Investments. FMR provides investment supervisory services, which include sub-advisory services, to Fidelity's family of mutual funds and exchange-traded funds, qualified tuition programs, privately offered unregistered investment funds, separately managed account clients, and various other institutional accounts.

Heller Financial, Inc. provided mercantile financing. It was acquired by GE Capital Corp. The company was located in Chicago, IL

JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics.

Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ.

Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA.

Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA.

Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA.

Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA.

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

ComHear, Inc. provides audio technology products and services for consumer, enterprise, and professional applications. Its products are powered by MyBeam, a beam forming technology and KAP enhancement software which provides immersive 3-D audio soundscapes. The company was founded by Randy Granovetter in 2013 and is headquartered in San Diego, CA.

Part of MVM Partners LLP, MVM (U.S.), Inc. provides investment advice. The company is based in Boston, MA.

MD Revolution, Inc. engages in the provision of a digital care management platform. Its product platform include care management features, clinical tools, patient engagement tools, and integration. The firm solutions also include Chronic Care Management; Remote Patient Monitoring; Behavioral Health Integration; Annual Wellness Visits; Transitional Care Management; Whole Person Care; Clinical Care Teams; And Care Program Design. The company was founded by Samir Damani in 2011 and is headquartered in Solana Beach, CA.

AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.

Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong.

Fidelity Investments, Inc. operates as a financial services company. The company is headquartered in Boston, MA.

IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.

Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA.

Tybourne Capital provides investment services. The private company is based in San Francisco, CA.

Protillion Biosciences, Inc. is a company based in Burlingame, CA that was founded in 2019 by Will Greenleaf, David R. Walt, and Curtis Layton. The company specializes in commercializing disruptive technology for therapeutic antibody and binder discovery. The company's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run, enabling the identification of better antibody candidates on an exponentially faster timeline compared to current state-of-the-art antibody discovery and optimization techniques that may take months of laborious laboratory procedures executed by highly-skilled practitioners. Curtis Layton has been the CEO since 2019.

Tybourne Capital Management HK Ltd (Venture Capital) is a venture capital firm, a subsidiary of Tybourne Capital Management (HK) Ltd founded in 2012. The firm is headquartered in Hong Kong.

Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.